Chronic pain, which is a multidimensional pathologic condition that have adverse effects on function and social and psychological well-being, has a high prevalence (~20%) worldwide. Pain treatment is based on the WHO ladder, in which drugs are classified into three steps depending on the intensity of pain. However, the pharmacological arsenal is not too extensive, and the most used drugs (NSAIDs, opioids) may cause a number of adverse effects upon repetitive use. The best example are opioids. Opioids are the most potent drugs used in pain relief. However, chronic opioid administration may lead to tolerance to the analgesic effects and severe adverse effects (e.g. dependence, constipation, respiratory depression), limiting its use. Accordingly, there is an urgent need for developing novel approaches to reduce/minimize uwanted effects when chronically using analgesic drugs. Precisely, the aim of our research is developing novel approaches, based on the combination of different drugs and/or the use of alternative therapies (e.g. photopharmacology, music), to reach an effective and safe treatment of pain.
Additional reading:
- Remote local photoactivation of morphine produces analgesia without opioid-related adverse effects. López-Cano M, Font J, Aso E, Sahlholm K, Cabré G, Giraldo J, De Koninck Y, Hernando J, Llebaria A, Fernández-Dueñas V, Ciruela F. Br J Pharmacol. 2023 Apr;180(7):958-974. doi: 10.1111/bph.15645.
- Optical Control of Adenosine-Mediated Pain Modulation. Hüll K, Fernández-Dueñas V, Schönberger M, López-Cano M, Trauner D, Ciruela F. Bioconjug Chem. 2021 Sep 15;32(9):1979-1983. doi: 10.1021/acs.bioconjchem.1c00387.
- Optical control of pain in vivo with a photoactive mGlu5 receptor negative allosteric modulator. Font J, López-Cano M, Notartomaso S, Scarselli P, Di Pietro P, Bresolí-Obach R, Battaglia G, Malhaire F, Rovira X, Catena J, Giraldo J, Pin JP, Fernández-Dueñas V, Goudet C, Nonell S, Nicoletti F, Llebaria A, Ciruela F. Elife. 2017 Apr 11;6:e23545. doi: 10.7554/eLife.23545.
- Predicting the antinociceptive efficacy of σ(1) receptor ligands by a novel receptor fluorescence resonance energy transfer (FRET) based biosensor. Gómez-Soler M, Fernández-Dueñas V, Portillo-Salido E, Pérez P, Zamanillo D, Vela JM, Burgueño J, Ciruela F. J Med Chem. 2014 Jan 9;57(1):238-42. doi: 10.1021/jm401529t.
- Synergistic interaction between fentanyl and a tramadol: paracetamol combination on the inhibition of nociception in mice. Fernández-Dueñas V, Poveda R, Sánchez S, Ciruela F. J Pharmacol Sci. 2012;118(2):299-302. doi: 10.1254/jphs.11161sc.
- Fentanyl-trazodone-paracetamol triple drug combination: multimodal analgesia in a mouse model of visceral pain. Fernández-Dueñas V, Poveda R, Fernández A, Sánchez S, Planas E, Ciruela F. Pharmacol Biochem Behav. 2011 May;98(3):331-6. doi: 10.1016/j.pbb.2011.01.023.
- Tolerance to the antinociceptive and antiexudative effects of morphine in a murine model of peripheral inflammation. Fernández-Dueñas V, Pol O, García-Nogales P, Hernández L, Planas E, Puig MM. J Pharmacol Exp Ther. 2007 Jul;322(1):360-8. doi: 10.1124/jpet.106.118901.